Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 761-770 of 1760 for

Edit search filters
  1. Long-Term Follow-up Protocol For Participants Treated With Gene-Modified T Cells

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Trial Using Keytruda As Initial Therapy In The Treatment Of Advanced Mycosis Fungoides

    Jacksonville, FL

  3. A Study To Evaluate AFPᶜ³³²T In Advanced HCC

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. Pembrolizumab Alone Or With Idelalisib Or Ibrutinib In Treating Patients With Relapsed Or Refractory Chronic Lymphocytic Leukemia Or Other Low-Grade B-Cell Non-Hodgkin Lymphomas

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. A Study To Evaluate The Safety, Tolerability, And Determine The Optimal Dose For The Expansion Cohorts Of VSV-IFNβ-NIS In Combination With Pembrolizumab In Patients With Refractory Solid Tumors

    Rochester, MN

  6. A Study To Compare The Effectiveness And Safety Of Bb2121 Versus Standard Regimens In Subjects With Relapsed And Refractory Multiple Myeloma (RRMM)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. A Study To Assess The Effectiveness And Safety Of Durvalumab Alone Or Combined With Bevacizumab In High Risk Of Recurrence HCC Patients After Curative Treatment

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. A Study Of Neoadjuvant/Adjuvant Durvalumab For The Treatment Of Patients With Resectable Non-small Cell Lung Cancer (AEGEAN)

    Scottsdale/Phoenix, AZ

  9. A Study To Evaluate The Safety Of Bb2121 In Subjects With High Risk, Newly Diagnosed Multiple Myeloma (NDMM) (KarMMa-4)

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  10. A Study To Evaluate The Safety And Effectiveness Of Idecabtagene Vicleucel To Treat Multiple Myeloma

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer